INBORN ERRORS OF METABOLISM (IEM) IAP UG Teaching slides

Similar documents
Metabolic Disorders. Chapter Thomson - Wadsworth

Inborn Errors of Metabolism (IEM)

The spectrum and outcome of the. neonates with inborn errors of. metabolism at a tertiary care hospital

Suspected Metabolic Disease in the Newborn Period Acute Management "What do I do?" Barbara Marriage, PhD RD Abbott Nutrition

Inborn Error Of Metabolism :

Inborn Errors of Metabolism in the Emergency Department. Will Davies June 2014

Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015

Newborn Screening & Methods for Diagnosing Inborn Errors of Metabolism

Newborn Screening: Blood Spot Disorders

Acute Management of Sick Infants with Suspected Inborn Errors of Metabolism

Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)

Metabolic diseases of the liver

THE ED APPROACH OF THE CHILD WITH SUSPECTED METABOLIC DISEASE

HA Convention 2016 Master course How to Handle Abnormal Newborn Metabolic Screening Results Causes, Management and Follow up

Module : Clinical correlates of disorders of metabolism Block 3, Week 2

Metabolic Changes in ASD. Norma J. Arciniegas, MD Simón E. Carlo, MD Instituto Filius

Newborn Screening in Manitoba. Information for Health Care Providers

Medical Foods for Inborn Errors of Metabolism

Inborn error of metabolism

Inborn Errors of Metabolism Clinical Approach to Diagnosis and Treatment

Newborn screening for congenital metabolic diseases Optional out-of-pocket tests Information Sheet

Spectrum of Inborn Errors of Metabolism in Jordan: Five Years Experience at King Hussein Medical Center

Training Syllabus CLINICAL SYLLABUS

7 Medical Genetics. Hemoglobinopathies. Hemoglobinopathies. Protein and Gene Structure. and Biochemical Genetics

Inborn Errors of Metabolism

Isovaleric Acidemia: Quick reference guide

National Metabolic Biochemistry Network Guidelines for the investigation of hypoglycaemia in infants and children

Nutritional Management of Inborn Errors of Metabolism. Kay Davis, RD, CSP Esther Berenhaut, RD, CSP, CSR Aug 28, 2017

Selective newborn screening of amino acid, fatty acid and organic acid disorders in the Kingdom of Bahrain.

So Much More Than The PKU Test

Current Management and Future Developments in Metabolic Disease

NEWBORN METABOLIC SCREEN, MINNESOTA

Most common metabolic disorders in childhood. Neonatal screening and diagnostic approach to the. Inborn errors of metabolism (IEM)

Metabolic Emergencies and the Pediatrician

Genética e Hígado: Cómo contribuye la genética en el algoritmo diagnóstico de la enfermedad hepática pediátrica? Nicholas Ah Mew, MD

HEREDITARY METABOLIC DISEASES

Fatty Acid Oxidation Disorders Organic Acid Disorders

Salicylate (Aspirin) Ingestion California Poison Control Background 1. The prevalence of aspirin-containing analgesic products makes

What s New in Newborn Screening?

Guideline for the diagnosis and management of isovaleryl-coa-dehydrogenase deficiency (isovaleric acidemia) - a systematic review -

What s New in Newborn Screening?

Prevalence of selected disorders of inborn errors of metabolism in suspected cases at a Tertiary Care Hospital in Karachi

The breakdown of fats to provide energy occurs in segregated membrane-bound compartments

Inborn Errors of Metabolism. Metabolic Pathway. Digestion and Fasting. How is Expanded Newborn Screening Different? MS/MS. The body is a factory.

Diagnosis of IEM. And Emergency Management

Work-Up and Initial Management of Common Metabolic Emergencies in the Inpatient Setting

Organic acidaemias (OAs) & Urea cycle disorders (UCDs) PRESENTATION & MANAGEMENT

Testing Strategy for Inborn Errors of Metabolism in the Neonate Aditi I. Dagli, Roberto T. Zori and Bryce A. Heese. DOI: /neo.

A Guide for Prenatal Educators

3 HYDROXY 3 METHYLGLUTARYL CoA (3 HMG CoA) LYASE DEFICIENCY RECOMMENDATIONS ON EMERGENCY MANAGEMENT OF METABOLIC DISEASES

Overview of Newborn Screening, Potential Uses of Residual Dried Blood Spots, and Protection of Privacy

ORIGINAL ARTICLE. Etiology and outcome of inborn errors of metabolism

Clinical Approach to Diagnosis of Lysosomal Storage Diseases

SYLLABUS FOR TRAINING IN CLINICAL PAEDIATRIC METABOLIC MEDICINE

INBORN ERRORS OF METABOLISM: REVIEW AND DATA FROM A TERTIARY CARE CENTER

Carnitine palmitoyl transferase 2 deficiency (CPT2) is a rare inherited disorder that occurs when

Understanding metabolic disease

Positive Newborn Screens: What do you do next?

Col Rama Krishna Sanjeev Military Hospital Chennai Prof Shanmughasundaram Mehta Hospital, Chennai

BCM 225 LECTURE ON INBORN ERRORS OF METABOLISM OJEMEKELE O.

e-learning Fatty Acid Oxidation Defects Camilla Reed and Dr Simon Olpin Sheffield Children s Hospital

Newborn Screening: Focus on Treatment

Summary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism

Introduction to Organic Acidemias. Hilary Vernon, MD PhD Assistant Professor of Genetic Medicine Johns Hopkins University 7.25.

Genetic Testing FOR DISEASES OF INCREASED FREQUENCY IN THE ASHKENAZI JEWISH POPULATION

Newborn Screening in Washington State Saving lives with a simple blood spot

Beyond the case for NBS in South Africa. Chris Vorster 28/05/2016

D evelopmental disabilities occur in approximately

For Your Baby s Health Department of Health

Neonatal Guidelines. Chapter 10: Metabolic V Date Revised : January 2017 Ratified 6 th February Date for Review: 1 st of March 2021

Syllabus for Training in Inborn Errors of Metabolism for Scientists and Medically Qualified Laboratory Staff

Lynne A. Wolfe, MS, ACNP, PNP, BC Department of Genetics Yale School of Medicine

CHRONIC MYELOGENOUS LEUKEMIA

a tidal wave of chronic illness

ANATOMY OF A METABOLIC CRISIS: FAOD-style. Mark S. Korson, MD Tufts Medical Center Boston, MA

Metabolic Disorders Screened Overseas but not Screened in Australia Condition Features Inherited Diagnosis Treatment Newborn Screen

Organic Acid Disorders

How MS/MS Revolutionized Newborn Screening

SELECTIVE VULNERABILITY (HYPOXIA AND HYPOGLYCEMIA)

TITLE: NURSING GUIDELINES FOR THE MANAGEMENT OF CHILDREN WITH METHYLMALONIC ACIDURIA. Eilish O Connell, Clinical Education Facilitator, NCIMD

Methylmalonic aciduria

Paediatric Clinical Chemistry

Childhood epilepsy: the biochemical epilepsies. Dr Colin D Ferrie Consultant Paediatric Neurologist Leeds General Infirmary

Fatty Acid Oxidation Disorders

Newborn Bloodspot Screening Information for parents

Most common is the congenital adrenogenital syndrome (AGS) or congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.

Metabolic Precautions & ER Recommendations

BIOTIN (BIOTINIDASE) DEFICIENCY Marc E. Tischler, PhD; University of Arizona

Newborn Bloodspot Screening Information for parents

Date of commencement: February Principal Investigator Dr. Jayesh J. Sheth CASE RECORD FORM

UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES Discipline of Biochemistry and Molecular Biology

(f) "Birthing center" means any facility that is licensed by the Georgia Department of Community Health as a birthing center;

MEDICAL COVERAGE GUIDELINES ORIGINAL EFFECTIVE DATE: 12/19/17 SECTION: MEDICINE LAST REVIEW DATE: LAST CRITERIA REVISION DATE: ARCHIVE DATE:

CLINICAL SIGNS SUGGESTIVE OF A NEUROMETABOLIC DISEASE. Bwee Tien Poll-The Amsterdam UMC The Netherlands

NEWBORN SCREENING IN JAPAN

Medifood 1. AMINOACID MIXES FOR PKU NON PKU AMINOACID MIXES GLYCOGEN STORAGE DISEASE LOW PROTEIN FOOD... 9

Fatty Acid Oxidation Disorders

NEONATAL HYPOGLYCEMIA HEATHER MCKNIGHT-MENCI, MSN, CRNP CHILDREN S HOSPITAL OF PHILADELPHIA

SCAD and GA-II: Truths and Confusions

JMSCR Volume 03 Issue 04 Page April 2015

Transcription:

INBORN ERRORS OF METABOLISM (IEM) 1

OBJECTIVES What are IEMs? Categories When to suspect? History and clinical pointers Metabolic presentation Differential diagnosis Emergency and long term management Expanded newborn screening 2

WHAT ARE IEMS? Monogenic disorders primarily Autosomal Recessive resulting from deficiency of: A critical enzyme in the intermediary pathways of carbohydrate, protein and lipid metabolism or A co factor which is responsible for activation of an apoenzyme in the same pathways 3

WHAT ARE IEMS? Clinical effects result from: Lack of the product Accumulation of immediate and remote precursors/ toxic byproducts Secondary metabolic consequences 4

IEMS: A FORMIDABLE CHALLENGE Number and Complexity Diverse clinical manifestations Mimic many common pediatric illnesses including sepsis, encephalopathy Limited availability of lab services Emergency and long term care Counseling 5

CATEGORIES OF IEM Carbohydrate Oxidative phosphorylation (OXPHOS) disorders Glycogen storage disorders, Galactosemia Protein Urea cycle disorders Organic acidemias Aminoacidopathies Lipids Fatty acid oxidation disorders (FAOD) Disorders of carnitine transport 6

CATEGORIES OF IEM Lysosomal storage disorders (LSD): Mucopolysaccharidosis (MPS), sphingolipidosis Peroxisomal disorders Mitochondrial disorders 7

CASE ILLUSTRATION A 6 month old male, 2nd order, born of non consanguinity, admitted for diarrhoea and dehydration H/O Sibling death with suspected Reye syndrome (encephalopathy) No developmental delay/ failure to thrive O/E: Moderate dehydration, rapid breathing, drowsy Hepatomegaly, firm, span 8cm 8

WHEN TO SUSPECT IEM? CLINICAL POINTERS HISTORY Developmental delay (DD), regression, mental retardation (MR) Refractory seizures Encephalopathy Rapid breathing (Acidotic) Failure to thrive, episodic vomiting Unusual body odours Life threatening illnesses following seemingly minor infections Consanguinity, family history of sibling deaths, DD/MR, seizures 9

ABNORMAL URINARY ODOURS Disorder Phenylketonuria Maple Syrup Urine Disease (MSUD) Isovaleric acidemia, Glutaric acidemia type 2 Multiple carboxylase deficiency Odor Musty Maple syrup or burnt sugar Sweaty feet Cat urine 10

WHEN TO SUSPECT IEM? CLINICAL POINTERS EXAMINATION Cataract, corneal clouding, cherry red spot Micro/ Macrocephaly, coarse facies Alopecia, intertrigo Hepatomegaly, liver dysfunction Splenomegaly Abnormal CNS examination Skeletal deformities 11

CLINICAL POINTERS TO DIAGNOSE IEM Feature Eye Cataract Corneal clouding Cherry red spot Skin Alopecia, intertrigo Hair Coarse, kinky Hepato ± splenomegaly Hepatomegaly & liver dysfunction Cardiomyopathy disorder Galactosemia MPS: Hurler, Scheie, Morquio, Maroteaux Lamy syndrome Tay Sachs, Niemann Pick Biotinidase deficiency Menkes kinky hair disease LSD: MPS, sphingolipidosis, GSD Galactosemia, tyrosinemia, GSD LSD, GSD, FAOD, mitochondrial disorders 12

CASE ILLUSTRATION: INVESTIGATIONS GRBS: 45 mg/dl; Urine ketones: Positive ABG: ph 7.09, pco2 14.8,BE 23.6, HCO3 4.5 Metabolic acidosis Anion gap 33 Wide NH3 328 µg/dl (N: 25 94) Hyperammonemia Lactate 28.8 mg/dl (N:2.5 20) Lactic acidosis FINAL DIAGNOSIS ORGANIC ACIDEMIA 13

WHEN TO SUSPECT IEM? LAB POINTERS Metabolic acidosis Wide anion gap Hyperammonemia Hypoglycemia: Urine Ketones (Ketotic/ non ketotic) Urine Reducing substances (Positive/ Negative) Lactic acidosis Altered liver function 14

Hyperammonemia Absent present Metabolic Acidosis Absent Amino acid disorders present Hypoglycemia Absent Urea Cycle disorders No Ketonuria Fatty Acid Oxidation disorders Lactic Acidosis OXPHOS disorders Ketosis Organic Acidemias GSD 15

DEFINITIVE DIAGNOSIS Blood: Tandem mass spectrometry for acyl carnitine, organic acids Plasma and urine amino acids (quantitative) Urine organic acids by chromatography Specific metabolite assays DNA mutation analysis Enzyme assays on skin fibroblasts or blood cells 16

DIFFERENTIAL DIAGNOSIS Sepsis: Can mimic, precipitate and complicate IEM Galactosemia predilection for E coli sepsis Negative CRP and blood culture in a rapidly deteriorating infant should alert to possible IEM Reye encephalopathy An important differential for FAOD with hepatomegaly, hypoglycemia, hyperammonemia and hepatic dysfunction 17

MANAGEMENT GOALS Prevention of formation of toxic metabolites Removal of toxic metabolites Increase activity of deficient enzyme by co factor therapy (Mega vitamins) Addition of deficient substrate Supply essential nutrients/ disease specific diet 18

MANAGEMENT: EMERGENCY ABC Correction of hypoglycemia and maintenance of blood sugars to suppress gluconeogenesis Correction of acidosis: IV Sodium bicarbonate with serial ABGs Carnitine supplementation Broad spectrum antibiotics including anaerobic cover 19

HYPERAMMONEMIA MANAGEMENT Hemodialysis for rapid reduction Decrease production: I.V. Arginine HCl Promote excretion: I.V. sodium benzoate and sodium phenyl acetate Calories: carbohydrate/ lipid; reintroduction of protein after 48 hours restricted to 1 g/kg with 50% essential amino acids Avoid valproate, steroids 20

Vitamin Dosage/ day Indications Biotin 10 50 mg Holo carboxylase deficiency Biotinidase Riboflavin 100 mg Glutaric aciduria Electron Transport Chain defects Thiamine 300 mg MSUD Pyruvate met defects Mitochondrial Vit B 12 1 2 mg Methyl malonic acidemia Homocystinuria Pyridoxine 50 100 mg Dependent seizures Homocystinuria 21

DIET MANAGEMENT Restriction of proteins: 6% of total energy Restriction of substrates which accumulate Homocystinuria: Methionine PKU: phenylalanine Special diets: PKU, MSUD, galactosemia Replacement of deficient nutrients Homocystinuria: cystein 22

EXPANDED NEWBORN SCREENING Pre symptomatic detection of newborns that includes several IEM Originated with the development of the Guthrie test for detecting phenylketonuria Dried Blood Spots: Heel prick blood at 48 72 hours of age on absorbent paper (Guthrie card) and analyzed by tandem mass spectrometry 23

IEMS ARE: Individually rare but collectively have an incidence of 1 in 5000 Presentation can occur at any age, even in adulthood Increasingly a primary/ differential diagnosis especially in infancy Index of suspicion The most difficult step in diagnosis is considering the possibility! 24

THANK YOU 25